MWNA
GILD icon

Marshall Wace North America’s Gilead Sciences GILD Stock Holding History

Marshall Wace North America’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$778K Sell
11,135
-1,828,378
-99% -$128M ﹤0.01% 1007
2021
Q2 		$127M Sell
1,839,513
-84,474
-4% -$5.64M 0.53% 36
2021
Q1 		$124M Buy
1,923,987
+654,400
+52% +$42.2M 0.51% 36
2020
Q4 		$74M Buy
1,269,587
+1,233,746
+3,442% +$74.4M 0.33% 70
2020
Q3 		$2.27M Sell
35,841
-71,433
-67% -$4.95M 0.01% 554
2020
Q2 		$8.25M Sell
107,274
-69,844
-39% -$5.35M 0.05% 287
2020
Q1 		$13.2M Sell
177,118
-1,302,055
-88% -$90M 0.1% 193
2019
Q4 		$96.1M Sell
1,479,173
-2,397,842
-62% -$156M 0.46% 59
2019
Q3 		$246M Buy
3,877,015
+458,819
+13% +$30M 1.4% 8
2019
Q2 		$231M Buy
3,418,196
+2,559,972
+298% +$168M 1.43% 12
2019
Q1 		$55.8M Sell
858,224
-135,082
-14% -$8.98M 0.39% 76
2018
Q4 		$62.1M Buy
993,306
+86,386
+10% +$6.04M 0.6% 45
2018
Q3 		$70M Buy
+906,920
New +$68.5M 0.48% 54
2018
Q2 		– Sell
-20,058
Closed -$1.51M – 1494
2018
Q1 		$1.51M Buy
+20,058
New +$1.59M 0.01% 890
2017
Q4 		– Sell
-352,434
Closed -$28.5M – 1445
2017
Q3 		$28.5M Sell
352,434
-371,933
-51% -$28.4M 0.18% 153
2017
Q2 		$51.4M Buy
+724,367
New +$48.2M 0.38% 63
2013
Q4 		$7.56M Buy
+100,546
New +$7M 0.16% 147
2013
Q3 		– Sell
-16,961
Closed -$869K – 647
2013
Q2 		$869K Buy
+16,961
New +$884K 0.07% 243

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Marshall Wace North America's GILD Position: Q3 2021 in Review

Marshall Wace North America reduced its Gilead Sciences (GILD) stake by 99% in Q3 2021, selling an estimated $128M and leaving 11,135 shares worth $778K. The position accounts for ﹤0.01% of the portfolio, ranked #1007.

Marshall Wace North America first reported a position in GILD in Q2 2013 and has held it in 18 quarters since. The position peaked at $246M in Q3 2019. 1,564 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • Marshall Wace North America held 11,135 shares of Gilead Sciences worth $778K as of Q3 2021.
  • Marshall Wace North America sold 1,828,378 Gilead Sciences shares in Q3 2021, an estimated $128M.
  • Gilead Sciences made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1007 holding.
  • Marshall Wace North America first reported a position in Gilead Sciences in Q2 2013 and has held it in 18 quarters since.
  • Marshall Wace North America's Gilead Sciences position peaked at $246M in Q3 2019.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.